| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |